Francois C, Mailliez A, Chretien S, Leguillette C, et al. Therapeutic impact of (18)F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer. Breast Cancer Res Treat 2024 Jun 5. doi: 10.1007/s10549-024-07386.
PMID: 38837087